Atossa Therapeutics Announces Successful In vitro Testing Results of COVID-19 Drug: AT-H201 Inhibits SARS-CoV-2 Infectivity of VERO Cells in Laboratory Culture
Stock Information for Atossa Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.